• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

连续十年儿童铜绿假单胞菌菌血症:临床特征、多药耐药危险因素分析及临床结局。

Pseudomonas aeruginosa bacteremia in children over ten consecutive years: analysis of clinical characteristics, risk factors of multi-drug resistance and clinical outcomes.

机构信息

Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Korea.

出版信息

J Korean Med Sci. 2011 May;26(5):612-8. doi: 10.3346/jkms.2011.26.5.612. Epub 2011 Apr 21.

DOI:10.3346/jkms.2011.26.5.612
PMID:21532850
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3082111/
Abstract

This study aimed to evaluate the clinical profiles, antibiotic susceptibility, risk factors of multi-drug resistance (MDR) and outcomes of P. aeruginosa bacteremia in children by retrospective methods at a tertiary teaching children's hospital in Seoul, Korea during 2000-2009. A total of 62 episodes were evaluated and 59 patients (95.2%) had underlying diseases. Multivariate analysis demonstrated that an intensive care unit (ICU) stay within the previous one month was the only independent risk factor for MDR P. aeruginosa bacteremia (odds ratio [OR], 6.8; 95% confidence interval [CI], 1.3-35.8, P = 0.023). The overall fatality rate associated with P. aeruginosa bacteremia was 14.5% (9 of 62). The fatality rate in patients with MDR P. aeruginosa was 57.1%, compared with 9.1% in non-MDR patients (OR 13.3; 95% CI 2.3-77.2, P = 0.006). However, the presence of respiratory difficulty was the only independent risk factor for overall fatality associated with P. aeruginosa bacteremia according to multivariate analysis (OR 51.0; 95% CI 7.0-369.0, P < 0.001). A previous ICU stay and presentation with respiratory difficulty were associated with acquisition of MDR P. aeruginosa and a higher fatality rate, respectively. Future efforts should focus on the prevention and treatment of P. aeruginosa bacteremia in high-risk children.

摘要

本研究旨在通过回顾性方法评估 2000-2009 年在韩国首尔的一家三级教学儿童医院的儿童铜绿假单胞菌血症的临床特征、抗生素敏感性、多重耐药(MDR)的危险因素和结局。共评估了 62 个病例,59 例(95.2%)患者存在基础疾病。多变量分析表明,在过去一个月内入住重症监护病房(ICU)是 MDR 铜绿假单胞菌血症的唯一独立危险因素(比值比 [OR],6.8;95%置信区间 [CI],1.3-35.8,P=0.023)。铜绿假单胞菌血症相关的总死亡率为 14.5%(62 例中的 9 例)。MDR 铜绿假单胞菌血症患者的死亡率为 57.1%,而非 MDR 患者的死亡率为 9.1%(OR 13.3;95%CI 2.3-77.2,P=0.006)。然而,多变量分析显示,存在呼吸窘迫是铜绿假单胞菌血症总死亡率的唯一独立危险因素(OR 51.0;95%CI 7.0-369.0,P<0.001)。先前的 ICU 入住和出现呼吸窘迫分别与获得 MDR 铜绿假单胞菌和更高的死亡率相关。未来应重点关注高危儿童中铜绿假单胞菌血症的预防和治疗。

相似文献

1
Pseudomonas aeruginosa bacteremia in children over ten consecutive years: analysis of clinical characteristics, risk factors of multi-drug resistance and clinical outcomes.连续十年儿童铜绿假单胞菌菌血症:临床特征、多药耐药危险因素分析及临床结局。
J Korean Med Sci. 2011 May;26(5):612-8. doi: 10.3346/jkms.2011.26.5.612. Epub 2011 Apr 21.
2
Pseudomonas aeruginosa bacteremia in children: analysis of trends in prevalence, antibiotic resistance and prognostic factors.儿童铜绿假单胞菌血症:患病率、抗生素耐药性及预后因素的趋势分析
Pediatr Infect Dis J. 2000 Oct;19(10):959-63. doi: 10.1097/00006454-200010000-00003.
3
Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.发热性中性粒细胞减少症儿童和青少年铜绿假单胞菌血症的临床特征、结局及抗生素耐药性的影响:一项回顾性研究
BMC Infect Dis. 2017 Jul 17;17(1):500. doi: 10.1186/s12879-017-2597-0.
4
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality.多重耐药铜绿假单胞菌血流感染:危险因素和死亡率。
Epidemiol Infect. 2011 Nov;139(11):1740-9. doi: 10.1017/S0950268810003055.
5
Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa.中性粒细胞减少癌症患者血流感染铜绿假单胞菌所致多药耐药的临床预测模型。
Antimicrob Agents Chemother. 2020 Mar 24;64(4). doi: 10.1128/AAC.02494-19.
6
Pseudomonas Bacteremia in Children: Clinical and Microbiologic Features and Risk Factors of Mortality: A Retrospective Cohort Study.儿童假单胞菌血症:临床和微生物学特征以及死亡风险因素:一项回顾性队列研究。
Pediatr Infect Dis J. 2023 Jun 1;42(6):479-484. doi: 10.1097/INF.0000000000003891. Epub 2023 Feb 22.
7
Extensively drug-resistant Pseudomonas aeruginosa: risk of bloodstream infection in hospitalized patients.广泛耐药铜绿假单胞菌:住院患者发生血流感染的风险。
Eur J Clin Microbiol Infect Dis. 2012 Oct;31(10):2791-7. doi: 10.1007/s10096-012-1629-3. Epub 2012 May 4.
8
Pseudomonas aeruginosa bacteraemia: independent risk factors for mortality and impact of resistance on outcome.铜绿假单胞菌败血症:死亡率的独立危险因素及耐药性对预后的影响
J Med Microbiol. 2014 Dec;63(Pt 12):1679-1687. doi: 10.1099/jmm.0.073262-0. Epub 2014 Sep 26.
9
Antimicrobial Susceptibility Trends and Risk Factors for Antimicrobial Resistance in Bacteremia: 12-Year Experience in a Tertiary Hospital in Korea.血流感染中的抗菌药物敏感性趋势和抗菌药物耐药性的危险因素:韩国一家三级医院 12 年的经验。
J Korean Med Sci. 2021 Nov 8;36(43):e273. doi: 10.3346/jkms.2021.36.e273.
10
Pseudomonas aeruginosa bacteremia over a 10-year period: multidrug resistance and outcomes in transplant recipients.10年期间铜绿假单胞菌血症:移植受者的多重耐药性及预后
Transpl Infect Dis. 2009 Jun;11(3):227-34. doi: 10.1111/j.1399-3062.2009.00380.x. Epub 2009 Mar 2.

引用本文的文献

1
Clinical Analysis of Infections in Children Undergoing Chemotherapy or Hematopoietic Cell Transplantation: A Multicenter Nationwide Study.化疗或造血细胞移植患儿感染的临床分析:一项全国多中心研究
J Clin Med. 2025 May 26;14(11):3714. doi: 10.3390/jcm14113714.
2
A case report of a patient with recurrent and severe infections highlighting the importance of considering inborn errors of immunity.一例复发性严重感染患者的病例报告,强调了考虑遗传性免疫缺陷病的重要性。
Front Pediatr. 2024 Feb 28;12:1340367. doi: 10.3389/fped.2024.1340367. eCollection 2024.
3
Factors associated with multidrug-resistant bacteria in healthcare-associated infections: a pediatric intensive care unit case-control study.与医源性感染中多重耐药菌相关的因素:儿科重症监护病房病例对照研究。
Einstein (Sao Paulo). 2022 Apr 22;20:eAO6704. doi: 10.31744/einstein_journal/2022AO6704. eCollection 2022.
4
A rapid evidence assessment exploring whether antimicrobial resistance complicates non-infectious health conditions and healthcare services, 2010-20.一项快速证据评估,探究2010年至2020年期间抗菌药物耐药性是否会使非传染性健康状况和医疗服务变得复杂。
JAC Antimicrob Resist. 2021 Nov 15;3(4):dlab171. doi: 10.1093/jacamr/dlab171. eCollection 2021 Dec.
5
Ecthyma gangrenosum due to Pseudomonas aeruginosa sepsis as initial manifestation of X-linked agammaglobulinemia: a case report.绿脓杆菌败血病导致坏疽性脓皮病:X 连锁无丙种球蛋白血症的首发表现:一例报告。
BMC Pediatr. 2020 Dec 1;20(1):540. doi: 10.1186/s12887-020-02436-8.
6
Pseudomonas aeruginosa bloodstream infection at a tertiary referral hospital for children.儿童三级转诊医院的铜绿假单胞菌血流感染。
BMC Infect Dis. 2020 Oct 7;20(1):729. doi: 10.1186/s12879-020-05437-1.
7
Multiple antibiotic resistance as a risk factor for mortality and prolonged hospital stay: A cohort study among neonatal intensive care patients with hospital-acquired infections caused by gram-negative bacteria in Vietnam.多重抗生素耐药性作为死亡和住院时间延长的危险因素:越南新生儿重症监护病房革兰氏阴性菌医院获得性感染患者的队列研究。
PLoS One. 2019 May 8;14(5):e0215666. doi: 10.1371/journal.pone.0215666. eCollection 2019.
8
Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.发热性中性粒细胞减少症儿童和青少年铜绿假单胞菌血症的临床特征、结局及抗生素耐药性的影响:一项回顾性研究
BMC Infect Dis. 2017 Jul 17;17(1):500. doi: 10.1186/s12879-017-2597-0.
9
[Relationship between fever degree and prognosis in children with bacterial bloodstream infection].[小儿细菌性血流感染发热程度与预后的关系]
Zhongguo Dang Dai Er Ke Za Zhi. 2017 May;19(5):560-563. doi: 10.7499/j.issn.1008-8830.2017.05.016.
10
Fingerprint Analysis and Identification of Strains ST309 as a Potential High Risk Clone in a Population Isolated from Children with Bacteremia in Mexico City.指纹分析及菌株ST309的鉴定:墨西哥城儿童菌血症分离人群中一种潜在的高风险克隆株
Front Microbiol. 2017 Mar 1;8:313. doi: 10.3389/fmicb.2017.00313. eCollection 2017.

本文引用的文献

1
Multidrug resistant Pseudomonas aeruginosa infection in children undergoing chemotherapy and hematopoietic stem cell transplantation.儿童化疗和造血干细胞移植后耐多药铜绿假单胞菌感染。
Haematologica. 2010 Sep;95(9):1612-5. doi: 10.3324/haematol.2009.020867. Epub 2010 Mar 19.
2
Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.血管内导管相关感染的诊断与管理临床实践指南:美国感染病学会2009年更新版
Clin Infect Dis. 2009 Jul 1;49(1):1-45. doi: 10.1086/599376.
3
Pseudomonas aeruginosa bacteremia over a 10-year period: multidrug resistance and outcomes in transplant recipients.10年期间铜绿假单胞菌血症:移植受者的多重耐药性及预后
Transpl Infect Dis. 2009 Jun;11(3):227-34. doi: 10.1111/j.1399-3062.2009.00380.x. Epub 2009 Mar 2.
4
Clinical impact of imipenem-resistant Pseudomonas aeruginosa bloodstream infections.耐亚胺培南铜绿假单胞菌血流感染的临床影响
J Infect. 2009 Apr;58(4):285-90. doi: 10.1016/j.jinf.2009.02.010. Epub 2009 Mar 17.
5
Low-dose hydrocortisone in pediatric septic shock: an exploratory study in a third world setting.小剂量氢化可的松治疗小儿感染性休克:在第三世界环境中的一项探索性研究。
Pediatr Crit Care Med. 2009 Jan;10(1):121-5. doi: 10.1097/PCC.0b013e3181936ab3.
6
Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection.铜绿假单胞菌血流感染患者30天死亡率的预测因素:延迟选择合适抗生素的影响。
Antimicrob Agents Chemother. 2007 Oct;51(10):3510-5. doi: 10.1128/AAC.00338-07. Epub 2007 Jul 23.
7
Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment.铜绿假单胞菌血流感染:恰当初始抗菌治疗的重要性
Antimicrob Agents Chemother. 2005 Apr;49(4):1306-11. doi: 10.1128/AAC.49.4.1306-1311.2005.
8
Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.美国医院的医院获得性血流感染:来自一项全国性前瞻性监测研究的24179例病例分析。
Clin Infect Dis. 2004 Aug 1;39(3):309-17. doi: 10.1086/421946. Epub 2004 Jul 15.
9
Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections.医院获得性多重耐药铜绿假单胞菌感染的危险因素及临床结局
J Hosp Infect. 2004 Jun;57(2):112-8. doi: 10.1016/j.jhin.2004.03.021.
10
Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.铜绿假单胞菌血症:死亡危险因素及有效抗菌治疗延迟应用对临床结局的影响
Clin Infect Dis. 2003 Sep 15;37(6):745-51. doi: 10.1086/377200. Epub 2003 Aug 23.